How you #LoveYourEyes: clinicians, media, educators weigh in on World Sight Day 2021

Video

On October 14, we celebrate World Sight Day by pledging to receive annual eye exams, preventing or slowing vision loss, and showing love for our eyes.

Every second Thursday of October, the globe celebrates World Sight Day. Created by the International Agency for the Prevention of Blindness (IAPB), World Sight Day raises awareness of blindness and vision impairment.

This year's theme is #LoveYourEyes. We've asked ophthalmologists, optometrists, retina specialists, and members of the Ophthalmology Times Europe team to share what their vision means to them and what they would miss seeing the most if they were to lose their vision.

The International Agency for the Prevention of Blindness has set a goal for 1 million people to pledge to get their eyes tested. Eye exams are one of the most effective ways to fight vision loss as clinicians can detect diseases early and begin sight-saving therapies.

Take the pledge to get your eyes examined, and share your pledge to encourage others to do the same!

About the International Agency for the Prevention of Blindness

The International Agency for the Prevention of Blindness coordinates international blindness prevention activities and resources.

IAPB began in the mid-1970’s when Sir John Wilson and his colleagues drew attention to the growing issue of global blindness. In 1975, the IAPB was born, with Sir John Wilson at the helm as the Founder President. Additional founding members were the International Council of Ophthalmology (ICO) and the World Blind Union (WBU).

From the beginning, IAPB set its sights on linking professional bodies, non-governmental organisations, educational institutions and individuals in the fight against blindness. Today, it organises events, programmes and campaigns to combat vision loss.

World Sight Day is one of the IAPB’s largest initiatives every year, but they host events, educational resources and opportunities to fight blindness year-round. To learn more about how you can get involved in their fight against vision loss and impairment, visit their website.

Related Content: Gene Therapy | Retina | Cataract & Refractive

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Marjorie Rah, OD, PhD, FAAO
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
Trukera Medical rebranding ushers in new era of expansion into cornea market
Related Content
© 2024 MJH Life Sciences

All rights reserved.